Posts in category: Company Announcement

Vadodara, India / 21/05/2025 –

Sudeep Pharma Limited, a leading Indian manufacturer of pharmaceutical and nutraceutical ingredients, has announced the acquisition of Nutrition Supplies Services (NSS), a European pioneer in advanced micronutrient premixes. The move marks a significant leap in Sudeep’s global ambitions to strengthen its portfolio in infant formula, medical nutrition, and functional food solutions.

Headquartered in Ireland, a global hub for dairy and pediatric nutrition, NSS brings over 40 years of industry experience, including years of deep specialization in clean-label premixes, HMOs, and probiotic blends developed to meet EU and WHO standards. NSS has built long-standing partnerships with some of the world’s leading pediatric, clinical nutrition, and food & beverage companies, supported by a state-of-the-art manufacturing facility, regulatory excellence, and a strong innovation track record.

This strategic move positions Sudeep Pharma to seamlessly integrate high-end premix capabilities with its mineral and specialty ingredients portfolio, global distribution across 100+ countries, and regulatory strength. The combined platform enhances the company’s ability to drive innovation, improve supply chain agility, and accelerate access to fortified and science-backed nutrition in high-growth regions across Europe, Asia, Africa, and the Middle East.

“This is a transformative milestone in our global journey,” said Shanil Bhayani, Director, Sudeep Pharma Limited. “NSS’s deep-rooted expertise and reputation in Europe perfectly complement our scale, regulatory strength, and customer-first approach. Together, we’re creating a world-class platform for tomorrow’s nutrition.”

Sudeep Pharma Limited, part of the Sudeep Group, is a global leader in the production of pharmaceutical excipients, food-grade minerals, and specialty ingredients. With a legacy of over 35 years, the group is known for its commitment to quality, innovation, and strategic global growth across pharmaceutical, nutraceutical, and specialty nutrition domains.

Vadodara, India, July 5, 2024 – Sudeep Pharma Private Limited’s promoters have completed the acquisition of shares from their joint venture partners – JRS PHARMA, regaining 100% ownership of the company. This strategic move represents a significant step in Sudeep Pharma’s ongoing growth and development, enabling the company to pursue its vision.”

Promoters of Sudeep Pharma, Sujit Bhayani & Family, entered into a joint venture in 2015 with JRS Pharma. Combining JRS Pharma’s expertise in excipients with Sudeep Pharma’s technological advancements and robust manufacturing capabilities resulted in significant growth and valuable cooperation over the past nine years.

Sudeep Pharma remains dedicated to delivering cutting-edge pharmaceutical solutions, maintaining the highest standards of quality, and ensuring continued customer satisfaction. The company is poised to accelerate its research and development initiatives, expand its product portfolio, and pursue new opportunities for global market leadership.

Both Sudeep Pharma and JRS Pharma assure all stakeholders that this transaction will have no impact on current operations or product availability. Customers can expect to receive the same exceptional levels of service and product quality that both companies have consistently provided.

About Sudeep Pharma Private Limited:

Established in 1989, Sudeep Pharma Group is a leading manufacturer of specialty ingredients for the pharmaceutical, nutraceutical, and food industries. Starting with one excipient manufacturing facility, the group has expanded significantly, now operating six manufacturing facilities globally. Sudeep Pharma offers a comprehensive product portfolio that includes pharmaceutical excipients, mineral actives, and specialty ingredients tailored for the nutraceutical and food industries. The company prioritizes leveraging its technological expertise to innovate solutions for sustained growth.

Committed to setting new benchmarks in the healthcare industry, Sudeep Pharma aims to continue expanding its business both organically and inorganically. The company is actively enhancing its presence in India, the USA, and Europe through its subsidiaries, maintaining a strong focus on quality, integrity, and customer satisfaction.